1) Internal mammary artery
乳内动脉
1.
Application of bilateral skeletonized internal mammary artery in coronary artery bypass grafting;
骨骼化双侧乳内动脉在冠状动脉旁路移植术中的应用
2.
Nowadays, clinicians generally use the internal mammary artery, radial artery and the great saphenous vein for coronary artery bypass grafting.
目前临床上常用的血管桥有乳内动脉、桡动脉和大隐静脉,3种桥血管不同的组织结构、对血管活性物质不同的反应性和血管壁平滑肌受体分布的不同,与移植血管痉挛的发生率及近远期通畅率密切相关,是关系到冠状动脉旁路移植术手术成败的重要因素之一。
3.
Left internal mammary artery(IMA) was used in 1 case,left IMA and single radial artery(RA) in 14,left IMA and bilateral RA in 54,bilateral IMA and RA in 3 and bilateral RA in 2.
应用左乳内动脉(IMA)1例,左IMA加单挠动脉(RA)14例,左IMA加双RA 54例,双IMA加双RA 3例,双RA 2例。
2) Internal mammary artery
内乳动脉
1.
Application of left internal mammary artery and radial artery at same time for coronary artery bypass graft operation;
同时应用内乳动脉和桡动脉行冠状动脉搭桥术
2.
Study on clinical anatomy and histological characters of internal mammary artery and radial artery;
内乳动脉和桡动脉的临床解剖与组织学研究
3.
Coronary bypass revascularization with radial artery and internal mammary artery grafts;
桡动脉和内乳动脉在冠状动脉旁路术中的应用(英文)
4) human intramammary artery
人乳内动脉
1.
The purpose of this study was to investigate the vasorelaxing effect of vasonatrin peptide (VNP) on human intramammary artery (HIMA).
为了研究血管钠肽 (VNP)对人乳内动脉 (humanintramammaryartery ,HIMA)的舒张作用及其机制 ,采用离体血管灌流的方法 ,观察VNP对内皮完整和去内皮HIMA的舒张作用 ,以及HS 142 1、TEA、8 Br cGMP和镁蓝 (MB)对这一过程的影响。
5) LIMA
[英]['li:mə] [美]['limə]
左乳内动脉
1.
The objective of this study was to assesse the flow of sequential and non-sequential left internal mammary artery(LIMA)grafting in off-pump coronary artery bypass grafting(OPCABG),and present the objective evidence for the clinical using.
背景: 左乳内动脉旁路移植术以疗效可靠、远期通畅率高而成为冠心病外科治疗的首选和标准技术。
6) right internal mammary artery (RIMA)
右乳内动脉
补充资料：锁骨下动脉-锁骨下动脉-颈动脉旁路术
锁骨下动脉-锁骨下动脉-颈动脉旁路术
适用于大动脉炎所致的左锁骨下动脉和左颈总动脉起始处缩窄、闭塞而无名动脉通畅者，无名动脉分叉处缩窄、闭塞而左锁骨下动脉通畅者。手术在全麻下取双侧颈部横切口。显示双侧锁骨下动脉，用0.7～0.8cm口径的人工血管，经胸锁乳突肌后方隧道，作人工血管与锁骨下动脉端-侧吻合。若颈总动脉起始处有缩窄、闭塞者，加作颈部垂直切口，显露颈总动脉，再以等粗人工血管与颈总动脉及移植于两锁骨下动脉间的人工血管分别作端-侧吻合。手术可纠正或改善脑部和左上肢的血液供应。
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条